Resources To Prevent Youth Vaping Act
12/31/2022, 5:05 AMSummary of Bill HR 4629
Bill 117 HR 4629, also known as the Resources To Prevent Youth Vaping Act, is a piece of legislation introduced in the US Congress aimed at addressing the issue of youth vaping. The bill seeks to provide resources and funding to prevent and reduce youth vaping, which has become a growing concern in recent years.The bill includes provisions for funding education and prevention programs targeted at youth, as well as research into the health effects of vaping on young people. It also calls for increased enforcement of laws prohibiting the sale of vaping products to minors, as well as measures to restrict the marketing and advertising of these products to youth.
Additionally, the Resources To Prevent Youth Vaping Act includes provisions for the development of regulations to ensure the safety and quality of vaping products, as well as measures to increase public awareness of the risks associated with vaping. Overall, the bill aims to address the rising rates of youth vaping and protect young people from the potential health risks associated with these products. It represents a bipartisan effort to tackle this important public health issue and provide resources to prevent and reduce youth vaping.
Congressional Summary of HR 4629
Resources to Prevent Youth Vaping Act
This bill directs the Food and Drug Administration (FDA) to collect user fees on products that it deems by regulation to be tobacco products, including electronic nicotine delivery systems, and addresses related issues. Currently, the FDA is authorized to collect user fees only on specified classes of tobacco products.
The bill increases the total amount of such fees to be collected for FY2022. For each fiscal year after, the total amount of such fees shall be adjusted according to changes in a price index.
Starting in FY2024, the FDA must assess user fees on classes of products that it has deemed by regulation to be tobacco products, unless the FDA fails to finalize a formula for assessing such fees on time. Once it is finalized, the FDA may only revise this formula by regulation.
The bill also requires each tobacco manufacturer and importer to periodically submit certain information related to the tobacco products that it sells or distributes in the United States.
The FDA must annually report to Congress about its use of such tobacco product fees.
